These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 6441624

  • 1. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
    Pødenphant J, Christiansen C, Catherwood BD, Deftos LJ.
    Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624
    [Abstract] [Full Text] [Related]

  • 2. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C, Rødbro P, Tjellesen L.
    Acta Med Scand; 1984 Sep; 216(1):11-7. PubMed ID: 6385631
    [Abstract] [Full Text] [Related]

  • 3. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ, Johansen J, Christiansen C.
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [Abstract] [Full Text] [Related]

  • 4. Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.
    Ismail F, Epstein S, Pacifici R, Droke D, Thomas SB, Avioli LV.
    Calcif Tissue Int; 1986 Oct; 39(4):230-3. PubMed ID: 3098385
    [Abstract] [Full Text] [Related]

  • 5. Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women.
    Johansen JS, Jensen SB, Riis BJ, Christiansen C.
    Metabolism; 1990 Nov; 39(11):1122-6. PubMed ID: 2233271
    [Abstract] [Full Text] [Related]

  • 6. Serum bone Gla protein and other biochemical estimates of bone turnover in early postmenopausal women during prophylactic treatment for osteoporosis.
    Pødenphant J, Christiansen C, Catherwood BD, Deftos LJ.
    Acta Med Scand; 1985 Nov; 218(3):329-33. PubMed ID: 3907290
    [Abstract] [Full Text] [Related]

  • 7. Changes in bone mineral content in women with natural menopause during treatment with female sex hormones.
    Dalén N, Furuhjelm M, Jacobson B, Lamke B.
    Acta Obstet Gynecol Scand; 1978 Nov; 57(5):435-7. PubMed ID: 726877
    [Abstract] [Full Text] [Related]

  • 8. Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures.
    Resch H, Pietschmann P, Krexner E, Woloszczuk W, Willvonseder R.
    Acta Endocrinol (Copenh); 1990 Jul; 123(1):14-8. PubMed ID: 2389624
    [Abstract] [Full Text] [Related]

  • 9. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women.
    Johansen JS, Riis BJ, Delmas PD, Christiansen C.
    Eur J Clin Invest; 1988 Apr; 18(2):191-5. PubMed ID: 2968266
    [Abstract] [Full Text] [Related]

  • 10. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF, Christiansen C, Transbøl I.
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [Abstract] [Full Text] [Related]

  • 11. Effect of etidronate disodium on bone turnover following surgical menopause.
    Smith ML, Fogelman I, Hart DM, Scott E, Bevan J, Leggate I.
    Calcif Tissue Int; 1989 Feb; 44(2):74-9. PubMed ID: 2492893
    [Abstract] [Full Text] [Related]

  • 12. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.
    Christiansen C, Riis BJ, Nilas L, Rødbro P, Deftos L.
    Lancet; 1985 Oct 12; 2(8459):800-1. PubMed ID: 2864532
    [Abstract] [Full Text] [Related]

  • 13. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
    Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Melsen F.
    Bone; 1989 Oct 12; 10(5):313-20. PubMed ID: 2690898
    [Abstract] [Full Text] [Related]

  • 14. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.
    Delmas PD, Wahner HW, Mann KG, Riggs BL.
    J Lab Clin Med; 1983 Oct 12; 102(4):470-6. PubMed ID: 6604769
    [Abstract] [Full Text] [Related]

  • 15. Effects of a short course of estrogen on mineral metabolism in postmenopausal women.
    Stock JL, Coderre JA, Mallette LE.
    J Clin Endocrinol Metab; 1985 Oct 12; 61(4):595-600. PubMed ID: 2993339
    [Abstract] [Full Text] [Related]

  • 16. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F.
    J Bone Miner Res; 2002 Oct 12; 17(10):1904-12. PubMed ID: 12369794
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein.
    Brixen K, Nielsen HK, Eriksen EF, Charles P, Mosekilde L.
    Calcif Tissue Int; 1989 Feb 12; 44(2):93-8. PubMed ID: 2783876
    [Abstract] [Full Text] [Related]

  • 18. Osteocalcin and bone mineral content in rheumatoid arthritis.
    Peretz A, Praet JP, Rozenberg S, Bosson D, Famaey JP, Bourdoux P.
    Clin Rheumatol; 1989 Mar 12; 8(1):42-8. PubMed ID: 2787225
    [Abstract] [Full Text] [Related]

  • 19. Bone GLA protein (BGP) levels and bone turnover in rheumatoid arthritis.
    Magaro M, Altomonte L, Mirone L, Zoli A, Corvino G.
    Br J Rheumatol; 1989 Jun 12; 28(3):207-11. PubMed ID: 2786438
    [Abstract] [Full Text] [Related]

  • 20. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI, Hart DM, Lindsay R, Leggate I, Hooke A.
    Obstet Gynecol; 1985 Dec 12; 66(6):789-92. PubMed ID: 4069480
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.